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Letter to Editor
Requirements for confirmation of PCR-RFLP
results of polymorphisms
Dear Editor
As clinical investigators and researchers exploring the role of insulin receptor gene
(INSR) in polycystic ovary syndrome (PCOS), we wish to express our concern about
the study by Tehrani et al. (1) that aimed to explore the correlation between INSR and
adiponectin genes and PCOS. We are afraid that it might have technical flaws and take
confusion and concerns to the readership.
First, in the Materials and Methods section the authors stated that this study was a
cross-sectional study, while in the Conclusion section they called it a case-control study.
It is really confusing. This reveals a lack of statistical understanding of the cross-sectional
or case-control studies and reduces the power of the study.
Most critically, we are concerned about the performance of the polymerase chain
reaction-restriction fragments length polymorphism analysis (PCR-RFLP). Quality control
is a major issue in the application of PCR-RFLP studies, and for this reason we usually
adopt some quality control procedures, including using positive and negative controls,
repeating the genotyping analysis, and confirming the results with DNA sequencing (2,
3). However, in this study no quality control program was represented in the genotyping
section.
A series of studies have investigated the different genotypes of INSR in PCOS and
control populations. Nearly all the reports showed that the least frequent genotype of
rs1799817 was TT in both control and PCOS groups (2, 4–13), while in this study the most
frequent one was TT. Meanwhile, for rs2059806, all the other reports showed that the
least frequent genotype was AA (2, 8, 12), while this study found that the most frequent
one was AA. Additionally, a study from Iran was included in these studies, which showed
that the genotype frequencies of CC/CT/TT of rs1799817 were 110/63/8 in control group
and 105/64/12 in PCOS group (2), and the genotypes of GG/GA/AA of rs2059806 were
93/70/18 in control group and 96/73/12 in PCOS group (2). In this study, the genotypes
of CC/CT/TT of rs1799817 were 7/54/95 in control population and 15/57/114 in PCOS
population, and the genotypes of GG/GA/AA of rs2059806 were 18/58/80 in control and
11/76/99 in PCOS population. This distribution of genotypes is completely contradictory
to the previously published one (2). Considering that they were carried out in the same
ethnicity, it is difficult to explain it. This disaccordance raised a question about the
molecular methods applied to define the genotypes. Further confirmation was required
to make their results persuasive.
The authors also listed the allele frequencies in Table III. When we calculated the
allele frequencies using the genotype frequencies provided by them, we obtained totally
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different results. For rs2059806 in PCOS, the frequency of allele A (FA) was calculated
as FAA*2+FAG*1 = 99*2+76*1 = 274, and FG was calculated as FGG*2+FAG*1 = 11*2+76*1
= 98. However, the reported allele frequency of A was 110 and that of G was 76. Could
the authors explain how they calculated the allele frequencies?
Finally, in Table IV, the haplotype of Insulin in PCOS included CA, CG, TA, and CG,
which shows that a TG was likely mistaken as a CG, and therefore CG duplicated here.
Similarly, the same problem happened in the haplotype of Insulin in controls too. In
Figure 1, a TG might have been replaced by a CG too. What’s more, the data labels
of the haplotypes are not accurate either. There are three numbers without decimal
places, including 7, 28, and 25, which should be 7.0, 28.0, and 25.8.
Chun Feng1 M.D., Ping-ping Lv2 Ph.D. Candidate, Min Jin3 M.D., Ph.D., Jin-Ming
Shen4 M.D., Tian-he Huang5 M.D.
1Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang,
310006, China.
2Key Laboratory of Reproductive Genetics, Ministry of Education (Zhejiang University),
Hangzhou, Zhejiang, 310058, China.
3The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou,
Zhejiang, 310009, China.
4The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou,
Zhejiang, 310018, China.
5The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an,
Shanxi, 710061, China.
References
[1] Ramezani Tehrani F, DaneshpourM, Hashemi S, ZarkeshM, Azizi F. Relationship between polymorphism
of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reprod Med 2013; 11: 185–194.
[2] Ranjzad F, Mahmoudi T, Irani Shemirani A, Mahban A, Nikzamir A, Vahedi M, et al. A common variant in
the adiponectin gene and polycystic ovary syndrome risk. Mol Biol Rep 2012; 39: 2313–2319.
[3] Murillo R, Munoz D, Williams T, Mugeta N, Caballero P. Application of the PCR-RFLP method for the rapid
differentiation of Spodoptera exigua nucleopolyhedrovirus genotypes. J Virol Methods 2006; 135: 1–8.
[4] Chen ZJ, Shi YH, Zhao YR, Li Y, Tang R, Zhao LX, et al. [Correlation between single nucleotide
polymorphism of insulin receptor gene with polycystic ovary syndrome]. Zhonghua Fu Chan Ke Za
Zhi 2004; 39: 582–585.
[5] Conway GS, Avey C, Rumsby G. The tyrosine kinase domain of the insulin receptor gene is normal in
women with hyperinsulinaemia and polycystic ovary syndrome. Hum Reprod 1994; 9: 1681–1683.
[6] Lee EJ, Yoo KJ, Kim SJ, Lee SH, Cha KY, Baek KH. Single nucleotide polymorphism in exon 17 of the
insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population. Fertil
Steril 2006; 86: 380–384.
[7] Kashima K, Yahata T, Fujita K, Tanaka K. Polycystic ovary syndrome: association of a C/T single
nucleotide polymorphism at tyrosine kinase domain of insulin receptor gene with pathogenesis among
lean Japanese women. J Reprod Med 2013; 58: 491–496.
[8] Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O’Rahilly S, Clayton RN. Molecular scanning of the insulin
receptor gene inwomenwith polycystic ovarian syndrome. J Clin Endocrinol Metab 1996; 81: 1979–1983.
Page 218 https://doi.org/10.18502/ijrm.v17i3.4521
International Journal of Reproductive BioMedicine Requirements for confirmation of PCR-RFLP results of polymorphisms
[9] Mukherjee S, Shaikh N, Khavale S, Shinde G, Meherji P, Shah N, et al. Genetic variation in exon 17 of INSR
is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic
ovary syndrome. Eur J Endocrinol 2009; 160: 855–862.
[10] Skrgatic L, Baldani DP, Gersak K, Cerne JZ, Ferk P, Coric M. Genetic polymorphisms of INS, INSR and
IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women. Coll Antropol 2013;
37: 141–146.
[11] Ramos Cirilo PD, Rosa FE, Moreira Ferraz MF, Rainho CA, Pontes A, Rogatto SR. Genetic polymorphisms
associated with steroids metabolism and insulin action in polycystic ovary syndrome. Gynecol
Endocrinol 2012; 28: 190–194.
[12] Lee EJ, Oh B, Lee JY, Kimm K, Lee SH, Baek KH. A novel single nucleotide polymorphism of INSR gene
for polycystic ovary syndrome. Fertil Steril 2008; 89: 1213–1220.
[13] Siegel S, Futterweit W, Davies TF, Concepcion ES, Greenberg DA, Villanueva R, et al. A C/T single
nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with
polycystic ovary syndrome. Fertil Steril 2002; 78: 1240–1243.
https://doi.org/10.18502/ijrm.v17i3.4521 Page 219 Page 219
International Journal of Reproductive BioMedicine Feng et al.
Authors’ Answer
We thank Chun Feng and Colleagues for their interest in our paper (1). The
issues raised (letter) concerning our study are important; this reply letter clarifies our
methodology and corrects some results in detail.
A case-control study is a type of observational study in which two existing groups
differing in outcomes are identified and compared on the basis of some supposed
causal attribute, whereas a cross-sectional study provides a ”snapshot” of a population
at a single point in time and looks at both the diseases along with assumed covariates
simultaneously (2). Our studywas a case-control study in which a total of 186womenwith
PCOS using NIH criteria (cases) and 156 healthy women (controls) were recruited. At that
time, we used the polymerase chain reaction-restriction fragments length polymorphism
analysis (PCR-RFLP), and due to limited financial resources, we did not perform DNA
sequencing; however, we used positive and negative control groups in each PCR. There
was a typo error in the presentation of genotypes of INSR in our manuscript that created
all the discrepancies between our results and those previously reported (3). We believe
that the revised results presented in Table III will resolve the discrepancies. Results
presented in this table should be replaced with the previous results presented in Table
III of the original article and the corresponding texts in the Results section.
Table III: Genotype, allele, and haplotype frequencies in the two groups of study.
PCOS (n = 186) Controls (n = 156)
Genotype frequency (%)
Adiponectin
SmaI T > G (rs2241766)
GG 2 (1.1) 4 (2.6)
TT 142 (76.3) 106 (67.9)
TG 42 (22.6) 46 (29.5)
BsmaI C > A (rs1501299)
CC 92 (49.5) 77 (49.4)
AA 18 (9.7) 8 (5.1)
CA 76 (40.9) 71 (45.5)
Insulin
Pm1I T > C (rs1799817)
TT 114 (61.3) 95 (60.9)
CC 15 (8.1) 7 (4.5)
TC 57 (30.6) 54 (34.6)
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PCOS (n = 186) Controls (n = 156)
NsiI A > G (rs2059806)
AA 11 (5.9) 18 (11.5)
GG 99 (53.2) 80 (51.3)
AG 76 (40.9) 58 (37.2)
Allele frequency (%)
SmaI T > G
G 46 54
T 326 258
BsmaI C > A
C 260 225
A 112 87
Pm1I T > C
T 285 244
C 87 68
NsiI A > G
A 98 94
G 274 218
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Editorial
Thanks to Dr. Chun Feng and Colleagues for their comments on the article that was
published in our journal issued 2013; 11: 185-194. The modified version of this article will
be uploaded in our electronic version (March 2019).
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